Depressive Disorder, Major: all 2,806 studies
Page 22 of 29. Open to participants first (566), then studies with results posted, then the rest; newest registration first within each.
- Therapeutic Effectiveness of Exercise Associated to the Pharmacotherapy in Major DepressionCompletedNCT02427789Not applicable
- Cognitive Dysfunction and Glucagon-like Peptide-1 AgonistsCompletedNCT02423824Phase 3
- Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental IllnessCompletedNCT02421965Not applicable
- E-Compared-CH: Comparative Effectiveness Research on Internet-based Depression Treatment - Swiss TrialCompletedNCT02410616Not applicable
- Clinical Registry of Patients Under Treatment With Atypical AntipsychoticsCompletedNCT02409823
- HPA Axis Activity Due To Early Traumatic Stress and Metabolic SymptomsCompletedNCT02398877Not applicable
- Comparison of Yuxintine With Placebo in Treatment of MDDStatus unknownNCT02395263Phase 2
- Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)Active, not recruitingNCT02386670Not applicable
- Mindfulness-Based Cognitive Therapy Effect on Depression and C-Reactive Protein Levels After 8 Weeks of TreatmentCompletedNCT02385786Not applicable
- Maintenance rTMS for Treatment-resistant Depression (TRD): a One-year Double Blind Controlled StudyStatus unknownNCT02383693Phase 2/3
- Comparison of Anyu Peibo With Placebo in Treatment of MDDCompletedNCT02380066Phase 2
- Efficacy of Intermittent ThetaBurst Stimulation Compared to 10 Hz Stimulation on Dorsolateral Prefrontal Cortex in Treatment Resistant Major Depressive Disorder: a Double-blind Randomized StudyCompletedNCT02376491Not applicable
- Efficacy of Cognitive Behavioral to Hypnotherapeutic Treatment of DepressionCompletedNCT02375308Not applicable
- Memory Flexibility Training for DepressionCompletedNCT02371291Phase 1/2
- The Effect of Traumatic Childbirth on the Incidence of PTSD and Other Major Postpartum PsychopathologyStatus unknownNCT02370576
- Efficacy of Two Internet Delivered Intervention Programs for Depression: Behavioral Activation vs Physical ActivityCompletedNCT02369393Not applicable
- Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy VolunteersCompletedNCT02366364Phase 1
- Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive DisorderCompletedNCT02362529Early Phase 1
- e-Compared-S: Comparative Effectiveness Research on Internet-based Depression Treatment - Spanish TrialCompletedNCT02361684Not applicable
- Family Psychoeducation for Major Depressive DisorderStatus unknownNCT02348827Not applicable
- Neurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression DisorderStatus unknownNCT02346682Phase 4
- Characterization of the Prosocial and Prosexual Effects of GHBCompletedNCT02342366Not applicable
- Auricular Acupuncture vs. Progressive Muscle Relaxation in Patients With Anxiety Disorders or Major Depressive Disorder.CompletedNCT02340351Not applicable
- Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental IllnessCompletedNCT02334228Not applicable
- Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking VortioxetineCompletedNCT02332954Phase 4
- The Neurobiology of Approach Avoidance Training in DepressionCompletedNCT02330744Not applicable
- Prediction of Antidepressant Treatment Response Using Machine Learning Classification AnalysisStatus unknownNCT02330679Phase 4
- Microbiome of Depression & Treatment Response to CitalopramCompletedNCT02330068
- A Finnish Community Randomized Psychotherapy Effectiveness Study for Major DepressionCompletedNCT02314767Not applicable
- Storytelling Video Intervention for Depressed Primary Care Patients - Pilot TrialCompletedNCT02311725Not applicable
- Storytelling Video Intervention for Depressed Primary Care Patients - Open TrialCompletedNCT02309060Not applicable
- Task Sharing for the Care of Severe Mental Disorders in a Low-income CountryCompletedNCT02308956Phase 3
- Glutamate Probes in Adolescent DepressionCompletedNCT02307617
- Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety DisorderStatus unknownNCT02294305Phase 4
- Study of Morphological and Perfusion Imaging Predictors of Pejorative Outcome in Major Depressive DisorderCompletedNCT02286024
- Partnership in Medication Management (PIMM) in Patients With Mood DisordersStatus unknownNCT02285608Not applicable
- Gait, Depression, and Mind-body Therapy in SeniorsCompletedNCT02283541Not applicable
- Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive DisorderCompletedNCT02279966Phase 3
- Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive DisorderCompletedNCT02279953Phase 3
- Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression DisorderStatus unknownNCT02273154Phase 4
- Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive DisorderCompletedNCT02272517Phase 3
- Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005CompletedNCT02271412Phase 1
- A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)CompletedNCT02269540Early Phase 1
- Integral Assessment in Unipolar DepressionStatus unknownNCT02268487Phase 4
- Transdiagnostic iCBT for Depression and AnxietyCompletedNCT02266693Not applicable
- Incomplete Response in Late-Life Depression: Getting to Remission With BuprenorphineCompletedNCT02263248Phase 1/2
- Cognitive Training for Mood and Anxiety DisordersCompletedNCT02256566Not applicable
- Self Focus in Bipolar Disorder: A Functional Magnetic Resonance Imaging (fMRI) StudyCompletedNCT02253225
- Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive TherapyWithdrawnNCT02238730Not applicable
- Kappa Opioid Receptor Imaging in Depression (KOR Depression)TerminatedNCT02236702
- Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and PainCompletedNCT02232555Phase 3
- PET Imaging of Brain mGluR1 Receptors Using [18F]FIMXCompletedNCT02230592
- Games to Overcome Late Life DepressionCompletedNCT02229188Not applicable
- Investigating the Mechanisms of Mindfulness-based Cognitive Therapy (MBCT)CompletedNCT02226042Not applicable
- Neuromarkers Identification in Major Depressive Disorder Based on Monitoring MeasuresStatus unknownNCT02222012Not applicable
- Ketamine Infusions for Major Depression DisorderStatus unknownNCT02219867Not applicable
- Biomarkers of Social Sensitivity in Major DepressionCompletedNCT02214511
- Effectiveness of Repetitive Transcranial Magnetic Stimulation in Depressed PatientsStatus unknownNCT02213016Phase 4
- Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and IrritabilityWithdrawnNCT02212613Phase 3
- Blood Biomarkers in Major DepressionCompletedNCT02209142Not applicable
- Comparison of Orcinoside With Placebo in Treatment of MDDCompletedNCT02191384Phase 2
- The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled TrialCompletedNCT02191124Phase 4
- Reducing Residual Depressive Symptoms With Web-based Mindful Mood BalanceCompletedNCT02190968Not applicable
- Deep-brain Magnetic Stimulation (DMS) in the Treatment of Major Depressive DisorderCompletedNCT02184221Not applicable
- Neuronal Responses to Social Feedback in Major Depressive DisorderCompletedNCT02180607
- Chronotherapy Randomized Controlled TrialTerminatedNCT02176824Not applicable
- Biomarkers of Fast Acting Therapies in Major DepressionCompletedNCT02165449Phase 1
- CID 0911 - Adaptation of A Depression Treatment Intervention for HIV Patients in CameroonCompletedNCT02156622
- Neuroimaging MAO-B in Medication Free TR-MDD Using Novel TracerCompletedNCT02153281Not applicable
- Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood DisordersCompletedNCT02150681Phase 1
- Comparison of Anodal Transcranial Direct Current Stimulation (t-DCS) and Sham Stimulation in Patients With Treatment-resistant DepressionCompletedNCT02141776Phase 4
- Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major DepressionCompletedNCT02132286Phase 4
- Accelerated rTMS for Treatment-Resistant Major DepressionCompletedNCT02125799Phase 2/3
- Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia CaregiversCompletedNCT02122068Not applicable
- Pharmacogenetic Decision Support IT System for Psychiatric Hospitalization: RCTStatus unknownNCT02120729Not applicable
- TNS for Major Depressive Disorder: a Phase II Randomized Controlled TrialStatus unknownNCT02105376Phase 1/2
- Functional and Metabolic Changes in the Course of Antidepressive TreatmentCompletedNCT02099630
- Inflammation and Electroconvulsive TherapyTerminatedNCT02095639
- Trazodone Once a Day in Major Depression DisorderCompletedNCT02086929Phase 3
- Comparing Engage to PST for Late Life DepressionCompletedNCT02086201Not applicable
- Prevention of PTSD III: Neurocognitive Training of Emotional RegulationCompletedNCT02085512Not applicable
- Attention Bias Modification Treatment for Major Depressive Disorder in AdolescentsCompletedNCT02078258Not applicable
- Study of Intravenous NRX-1074 in Patients With Major Depressive DisorderCompletedNCT02067793Phase 2
- A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With AntidepressantsCompletedNCT02067299Phase 1
- The Efficacy And Cognitive Impairment Of Modified Electroconvulsive TherapyCompletedNCT02066077Not applicable
- Safety, Tolerability and Pharmacokinetics Study of LY03005CompletedNCT02055300Phase 1
- Integrated Chronotherapy for Perinatal DepressionCompletedNCT02053649Not applicable
- Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)CompletedNCT02051413Phase 4
- An Open Prospective Trial of IV Ketamine in Suicidal AdolescentsStatus unknownNCT02048423Phase 2/3
- Wake and Light Therapy to In-patients With Major Depression: Efficacy, Predictors and Patient ExperiencesCompletedNCT02047968Not applicable
- Deep Brain Stimulation (DBS) Therapy for Treatment Resistant DepressionActive, not recruitingNCT02046330Not applicable
- PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011CompletedNCT02039960
- The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major DepressionStatus unknownNCT02037503Phase 3
- Predictors of the Response and Relapse/Recurrence After ECT for Depressed PatientsCompletedNCT02032576Phase 4
- Can Magnetic Brain Stimulation Help Prevent Relapse in Depression?TerminatedNCT02029963Not applicable
- The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar DepressivesWithdrawnNCT02028026Phase 4
- Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of EmotionCompletedNCT02026622Not applicable
- Mobile Apps for the Treatment of DepressionWithdrawnNCT02024620Not applicable
- Objective Diagnostic Markers and Personalized Intervention in MDD PatientsStatus unknownNCT02023567Not applicable
- Enhancing Psychotherapy for Mood Disorders With Whole Body HyperthermiaTerminatedNCT02021149Not applicable